Latest News Archive

Please select Category, Year, and then Month to display items
Previous Archive
25 November 2019 | Story Leonie Bolleurs | Photo Supplied
Bennie
Bennie Botha brings another element of teaching to the classroom for future healthcare professionals. Here, he facilitates a session with students from the School of Nursing.

These days we are surrounded by technology. Interactive whiteboards, 3-D printers, smartphones, laptops, e-books, and virtual reality (VR).

VR was previously associated with the gaming industry, but today it has many uses, including the healthcare industry and more specifically, the field of nursing. 

A staff member in the School of Nursing at the University of the Free State (UFS), Bennie Botha, explains that he always had a fascination with VR. With VR being more affordable to the general user and with him working in the School of Nursing, he wanted to make a difference by providing a more financially sustainable way for students to integrate theory and practical work. 

It was then that Botha, in collaboration with staff from the Department of Computer Science and Informatics and the School of Nursing, developed a virtual environment to train Nursing students as part of his master’s thesis. The title of his dissertation is: Measuring the usability and user experience of virtual reality as a teaching and learning method for nursing students. His supervisor, Dr Lizette de Wet of the Department of Computer Science and Informatics, said the cooperation between two disciplines is important. “This research can make a big contribution towards teaching and learning,” she said. 
 
Adding to existing technology-rich environment

This simulation in a computer-generated environment adds another element to teaching. Instead of only listening to a lecturer, students are immersed in a relevant teaching scenario and are able to interact within a 3D medical institution, treating and taking care of 3D patients. 

The UFS School of Nursing has implemented this first for South Africa, using VR as an instrument to train nursing students. Currently, third-year students and postgraduate Paediatrics students are exposed to this way of training.

This new invention for the School of Nursing adds to the already existing technology-rich environment of the Clinical Simulation Unit within the school; a facility where healthcare students are exposed to training in a safe environment without harming the patient, using high-fidelity patient manikins.

Cost-effective simulation platform

According to Botha, VR provides a cost-effective simulation platform that can be used to augment high-fidelity simulations. “It is also a low-cost alternative for institutions that do not have the capital to implement high-fidelity simulations. By implementing new innovative teaching methods, we aim to provide quality healthcare professionals who can showcase the educational excellence of the School of Nursing at the UFS,” says Botha. 

Rector content

Rector and Vice-Chancellor, Prof Francis Petersen, visited the School of Nursing and engaged in the simulator-based game.
(Photo: Supplied)


He explains the process: “Virtual reality provides students with an opportunity to learn by engaging in a simulator-based game. The virtual environment requires the students to perform a respiratory foreign-body object simulation scenario. Before each virtual simulation session, students are briefed and given the relevant outcomes of the scenario. Students also receive a quick tutorial on the use of the controllers and the head-mounted display.”

“Once a session is complete, a debriefing session is held where students can reflect on the outcome of the simulation. They can view a recording of their own actions for self-reflection afterwards.”

Botha believes the VR environment he created for Nursing students contributes to the Fourth Industrial Revolution, giving the UFS a competitive edge in new developments and the use of innovative teaching and learning technology. 




News Archive

Nuclear Medicine on the forefront of cancer research
2017-07-10

Description: Nuclear Medicine on the forefront of cancer research Tags: Nuclear Medicine, cancer research, Dr Je’nine Horn-Lodewyk’s, tumour detection method, cancer, Department of Nuclear Medicine 

Dr Je’nine Horn-Lodewyk’s tumour detection method
could be the cost-effective breakthrough needed to decrease
the mortality rate in breast cancer patients.
Photo: Anja Aucamp

The field of Nuclear Medicine in South Africa and the rest of the world are expanding rapidly due to the development of hybrid cameras and new radiopharmaceuticals. These developments have a huge impact on the diagnosis and therapy of cancer.

The most advanced of these cameras, Positron emission tomography combined with normal CTs (PETCT), are not yet widely available in South Africa due to the cost of the cameras and the radiopharmaceuticals. A more cost-effective alternative can be of great benefit. To achieve this, the focus should be on developing new radiopharmaceuticals that can be used with the current cost-effective gamma cameras, according to University of the Free State researcher, Dr Je’nine Horn-Lodewyk from the Department of Nuclear Medicine.

Fluorodeoxyglucose (18F-FDG), a radiolabelled glucose analogue, is currently the radiopharmaceutical most commonly used in PET/CT imaging for mainly oncology indications. Although it is considered the gold standard for imaging in several malignancies, it does have certain disadvantages. An 18F-FDG PET/CT diagnostic imaging study can cost between R25 000 and R35 000 for a single patient in the private sector. The 18F-FDG is also more radioactive, which requires much stricter handling and shielding to avoid high radiation dosages to staff and patients.

Successful research potential innovative solution
In the search for the ideal radiopharmaceutical for tumour detection, the South African National Nuclear Energy Corporation (Necsa) developed a local synthesis process for ethylenedicysteine-deoxyglucose (EC-DG). EC-DG is also a glucose analogue similar to FDG. They succeeded in labelling the compound with Technetium-99-metastable-pertechnetate (99mTcO4-), the most common nuclear medicine isotope used for approximately 95% of nuclear medicine procedures, creating 99mTc-EC-DG.

In partnership with Dr Horn-Lodewyk, this compound was successfully used in various animal models and clinical scenarios, resulting in approval by the Medicine Control Council to use it in a human study. Research is also planned in order to investigate diagnostic accuracy in other cancers like lymphoma.  The end result of this research can produce a radiopharmaceutical that is cost effective, does not require the use of costly specialised equipment, has no significant side-effects, no special patient preparation, renders late imaging possible, and has decreased radiation risks.

Dr Horn-Lodewyk is grateful for the support of her mentor, Prof Anton Otto, as well as Dr Gert Engelbrecht, Head of the Department of Nuclear Medicine, Prof Jan Rijn Zeevaart from North-West University’s Preclinical Drug Development Platform and Necsa, and Judith Wagener from Necsa. This innovative research would also not have been possible without the financial assistance of Dr Glen Taylor and Eleanor van der Westhuizen in the Directorate of Research Development.

We use cookies to make interactions with our websites and services easy and meaningful. To better understand how they are used, read more about the UFS cookie policy. By continuing to use this site you are giving us your consent to do this.

Accept